trending Market Intelligence /marketintelligence/en/news-insights/trending/SdV9_4kVstZBuqJHMuVgCg2 content esgSubNav
In This List

ProQR Therapeutics appoints chief development strategy officer

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


ProQR Therapeutics appoints chief development strategy officer

ProQR Therapeutics NV appointed David Rodman as chief development strategy officer.

Rodman has served as a chief medical officer at miRagen Therapeutics Inc. and Nivalis Therapeutics Inc.